APA

Zell M., Husser C., Kuhlmann O., Schwab D., Uchimura T., Kemei T., Kawashima K., Yamane M. & Pähler A. (20141104). Metabolism and mass balance of SGLT2 inhibitor tofogliflozin following oral administration to humans. : Xenobiotica; the fate of foreign compounds in biological systems.

Chicago

Zell Manfred, Husser Christophe, Kuhlmann Olaf, Schwab Dietmar, Uchimura Takahide, Kemei Tomonori, Kawashima Kosuke, Yamane Mizuki and Pähler Axel. 20141104. Metabolism and mass balance of SGLT2 inhibitor tofogliflozin following oral administration to humans. : Xenobiotica; the fate of foreign compounds in biological systems.

Harvard

Zell M., Husser C., Kuhlmann O., Schwab D., Uchimura T., Kemei T., Kawashima K., Yamane M. and Pähler A. (20141104). Metabolism and mass balance of SGLT2 inhibitor tofogliflozin following oral administration to humans. : Xenobiotica; the fate of foreign compounds in biological systems.

MLA

Zell Manfred, Husser Christophe, Kuhlmann Olaf, Schwab Dietmar, Uchimura Takahide, Kemei Tomonori, Kawashima Kosuke, Yamane Mizuki and Pähler Axel. Metabolism and mass balance of SGLT2 inhibitor tofogliflozin following oral administration to humans. : Xenobiotica; the fate of foreign compounds in biological systems. 20141104.